1. Zhang, La, Zhang, Xiuzhen, Liu, Haichuan, Zhou, Baoyong, Jiang, Ning. 2024. MTFR2-dependent mitochondrial fission promotes HCC progression. In Journal of translational medicine, 22, 73. doi:10.1186/s12967-023-04845-6. https://pubmed.ncbi.nlm.nih.gov/38238834/
2. Wu, Qinjuan, Li, Xin, Long, Menghong, Xie, Xianfeng, Liu, Qing. 2023. Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinoma. In Scientific reports, 13, 18642. doi:10.1038/s41598-023-46057-4. https://pubmed.ncbi.nlm.nih.gov/37903971/
3. Bao, Zhongming, Yang, Ming, Guo, Yunhu, Ge, Qi, Zhang, Huaguo. 2024. MTFR2 accelerates hepatocellular carcinoma mediated by metabolic reprogramming via the Akt signaling pathway. In Cellular signalling, 123, 111366. doi:10.1016/j.cellsig.2024.111366. https://pubmed.ncbi.nlm.nih.gov/39182591/
4. Wang, Wei, Xiong, Meihua, Jiang, Lin, Chen, Zean, Shao, Yisen. 2020. MTFR2 Promotes the Proliferation, Migration, and Invasion of Oral Squamous Carcinoma by Switching OXPHOS to Glycolysis. In Frontiers in oncology, 10, 858. doi:10.3389/fonc.2020.00858. https://pubmed.ncbi.nlm.nih.gov/32537437/
5. Zhu, Hai, Wang, Gang, Zhu, Haixing, Xu, Aman. 2021. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments. In Journal of Cancer, 12, 3611-3625. doi:10.7150/jca.58158. https://pubmed.ncbi.nlm.nih.gov/33995638/
6. Li, Dan, Ji, YanMei, Guo, JiaLong, Guo, Qiang. 2021. Upregulated expression of MTFR2 as a novel biomarker predicts poor prognosis in hepatocellular carcinoma by bioinformatics analysis. In Future oncology (London, England), 17, 3187-3201. doi:10.2217/fon-2020-1160. https://pubmed.ncbi.nlm.nih.gov/34156259/
7. Lu, Guanming, Lai, Yuanhui, Wang, Tiantian, Liu, Ruilei, Li, Jie. 2019. Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells. In Aging, 11, 10203-10219. doi:10.18632/aging.102442. https://pubmed.ncbi.nlm.nih.gov/31740625/
8. Chen, Cheng, Tang, Yang, Qu, Wen-Dong, Song, Yong-Xiang, Ke, Xi-Xian. 2021. Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics. In BMC cancer, 21, 619. doi:10.1186/s12885-021-08378-3. https://pubmed.ncbi.nlm.nih.gov/34039308/
智鼠故事 
